Key result
LVNC is not associated with increased major cardiovascular events risk compared to dilated cardiomyopathy alone.
Why the study?
The prevalence, phenotypic CMR characteristics, clinical features, and outcomes of left ventricle non-compaction cardiomyopathy were unknown in the South Asian population.
Does the presence of left ventricle non-compaction confer an increased risk of MACE compared to dilated cardiomyopathy without LVNC in patients undergoing CMR?
Cohort (n=294)
No
Does the presence of left ventricle non-compaction confer an increased risk of MACE compared to dilated cardiomyopathy without LVNC in patients undergoing CMR?
Answers are grounded in this paper and cite their sources.
In a Pakistani cohort undergoing CMR for cardiomyopathy, the presence of LVNC did not confer an increased risk of MACE or mortality compared to dilated cardiomyopathy without LVNC.
Background: The exact prevalence of left ventricle non-compaction cardiomyopathy (LVNC) in south Asians is not known and phenotypic CMR characteristics, clinical features, and outcomes of LVNC remain unknown for the SA population. Objective: To evaluate clinical characteristics, cardiac magnetic resonance imaging features, and outcomes of patients with left ventricle non-compaction. Methods: This was a retrospective study of 294 patients undergoing cardiac MRI (CMR) for evaluation of cardiomyopathy from 2011 to 2020. Patients were stratified based on the presence or absence of left ventricle non-compaction (LVNC). Clinical characteristics, CMR features, and outcomes were evaluated. Results: Out of 294 patients, 18 patients had LVNC, with a prevalence of 6.1%. The mean age was 32 ± 13 years, and the majority were males (78%). The mean EF by echo was 36 ± 14 and by CMR was 31 ± 16 and the mean LV mass was 151 g. The mean LVEDV was 290 ± 154 and the mean LVESV was 211 ± 126. LGE was present in 33% of patients. The majority had uniform LV non-compaction (56%) followed by predominantly anterolateral and apical involvement (28%). Mitral regurgitation was the most common valvular pathology (33%). On follow-up of 37 months, the majority experienced at least one all-cause MACE (69%), while 14% of patients experienced mortality on follow-up. When compared with dilated cardiomyopathy patients without LVNC, the subjects were younger (p = 0.002) and had higher EF by an echocardiogram (0.001) and a lower arrhythmia hospitalization (p = 0.039). No difference was observed in overall MACE outcomes, mortality, and CMR features. Conclusion: The prevalence of LVNC is low in the studied population. Patients with LVNC have younger age, higher EF by echocardiogram, and lower arrhythmia hospitalization when compared with patients with dilated cardiomyopathy without evidence of LV non-compaction. The presence of LVNC does not confer an increased risk of MACE.
No takes yet. Share an insight, caveat, or question.
Shams et al. (2022) conducted a cohort in Cardiomyopathy (Left Ventricle Non-Compaction) (n=294). Left ventricle non-compaction vs. Dilated cardiomyopathy without left ventricle non-compaction was evaluated on All-cause major adverse cardiovascular events (MACE) (p=0.346). Left ventricle non-compaction was not associated with an increased risk of major adverse cardiovascular events compared to dilated cardiomyopathy without non-compaction.
Synapse has enriched 10 related papers. Consider them for comparative context: